233 related articles for article (PubMed ID: 25805926)
21. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
De Bruyne E; Andersen TL; De Raeve H; Van Valckenborgh E; Caers J; Van Camp B; Delaissé JM; Van Riet I; Vanderkerken K
Leukemia; 2006 Oct; 20(10):1870-9. PubMed ID: 16900214
[TBL] [Abstract][Full Text] [Related]
22. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
[TBL] [Abstract][Full Text] [Related]
23. Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes.
Mazurov D; Barbashova L; Filatov A
FEBS J; 2013 Mar; 280(5):1200-13. PubMed ID: 23289620
[TBL] [Abstract][Full Text] [Related]
24. Mechanical stress enhances CD9 expression in cultured podocytes.
Blumenthal A; Giebel J; Warsow G; Li L; Ummanni R; Schordan S; Schordan E; Klemm P; Gretz N; Endlich K; Endlich N
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F602-13. PubMed ID: 25503725
[TBL] [Abstract][Full Text] [Related]
25. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of CD9 in ovarian cancer is related to the induction of TNF-α gene expression and constitutive NF-κB activation.
Hwang JR; Jo K; Lee Y; Sung BJ; Park YW; Lee JH
Carcinogenesis; 2012 Jan; 33(1):77-83. PubMed ID: 22095071
[TBL] [Abstract][Full Text] [Related]
27. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
[TBL] [Abstract][Full Text] [Related]
29. cMET as a potential therapeutic target in gastric cancer (Review).
Teng L; Lu J
Int J Mol Med; 2013 Dec; 32(6):1247-54. PubMed ID: 24141315
[TBL] [Abstract][Full Text] [Related]
30. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
Al-Batran SE; Werner D
Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
[TBL] [Abstract][Full Text] [Related]
31. Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway.
Kotha J; Longhurst C; Appling W; Jennings LK
Exp Cell Res; 2008 May; 314(8):1811-22. PubMed ID: 18358474
[TBL] [Abstract][Full Text] [Related]
32. Functional relevance of tetraspanin CD9 in vascular smooth muscle cell injury phenotypes: a novel target for the prevention of neointimal hyperplasia.
Kotha J; Zhang C; Longhurst CM; Lu Y; Jacobs J; Cheng Y; Jennings LK
Atherosclerosis; 2009 Apr; 203(2):377-86. PubMed ID: 18799160
[TBL] [Abstract][Full Text] [Related]
33. Tetraspanin CD9: A Key Regulator of Cell Adhesion in the Immune System.
Reyes R; Cardeñes B; Machado-Pineda Y; Cabañas C
Front Immunol; 2018; 9():863. PubMed ID: 29760699
[TBL] [Abstract][Full Text] [Related]
34. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways.
Yang MD; Lai KC; Lai TY; Hsu SC; Kuo CL; Yu CS; Lin ML; Yang JS; Kuo HM; Wu SH; Chung JG
Anticancer Res; 2010 Jun; 30(6):2135-43. PubMed ID: 20651362
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
36. Switch from αvβ5 to αvβ6 integrin is required for CD9-regulated keratinocyte migration and MMP-9 activation.
Jiang X; Teng M; Guo X; Zhang D; Zhang Q; Zhang J; Huang Y
FEBS Lett; 2014 Nov; 588(21):4044-52. PubMed ID: 25265322
[TBL] [Abstract][Full Text] [Related]
37. Cloning of arctic lamprey Lethenteron camtschaticum cd9 with roles in the immune response.
Wu F; Su P; Chen L; Li M; Liu X; Li Q
J Fish Biol; 2012 Sep; 81(4):1147-57. PubMed ID: 22957860
[TBL] [Abstract][Full Text] [Related]
38. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
Hong IK; Kim YM; Jeoung DI; Kim KC; Lee H
Exp Mol Med; 2005 Jun; 37(3):230-9. PubMed ID: 16000878
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.
Nakata W; Hayakawa Y; Nakagawa H; Sakamoto K; Kinoshita H; Takahashi R; Hirata Y; Maeda S; Koike K
Int J Oncol; 2011 Dec; 39(6):1529-36. PubMed ID: 21785822
[TBL] [Abstract][Full Text] [Related]
40. Pro-MMP-9 upregulation in HT1080 cells expressing CD9 is regulated by epidermal growth factor receptor.
Herr MJ; Mabry SE; Jameson JF; Jennings LK
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):99-104. PubMed ID: 24246676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
